{"id":17,"date":"2021-04-09T11:20:26","date_gmt":"2021-04-09T09:20:26","guid":{"rendered":"https:\/\/www.crescat-advisory.de\/aktuelles\/?page_id=17"},"modified":"2021-06-23T17:15:40","modified_gmt":"2021-06-23T15:15:40","slug":"start","status":"publish","type":"page","link":"https:\/\/www.crescat-advisory.de\/aktuelles\/","title":{"rendered":"CRESCAT Advisory \u2013 Aktuelles"},"content":{"rendered":"<div id='av_section_1'  class='avia-section main_color avia-section-default avia-no-border-styling  avia-bg-style-scroll  avia-builder-el-0  avia-builder-el-no-sibling  headerhabibi  av-minimum-height av-minimum-height-100  container_wrap fullsize' style=' '   data-av_minimum_height_pc='100'><div class='container' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-17'><div class='entry-content-wrapper clearfix'>\n<div  style='padding-bottom:50px; margin: 0px 0px 0px 0px;' class='av-special-heading av-special-heading-h1  blockquote modern-quote  avia-builder-el-1  el_before_av_blog  avia-builder-el-first  '><h1 class='av-special-heading-tag '  itemprop=\"headline\"  >Aktuelles von CRESCAT Advisory<\/h1><div class='special-heading-border'><div class='special-heading-inner-border' ><\/div><\/div><\/div>\n<div  class='av-alb-blogposts template-blog  av-blog-meta-author-disabled av-blog-meta-comments-disabled av-blog-meta-category-disabled av-blog-meta-html-info-disabled av-blog-meta-tag-disabled '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Blog\" ><article class='post-entry post-entry-type-standard post-entry-877 post-loop-1 post-parity-odd bloglist-excerpt with-slider post-877 post type-post status-publish format-standard has-post-thumbnail hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/hks\/' rel='bookmark' title='Permanenter Link zu: Deal News: CRESCAT Advisory ber\u00e4t die Eigent\u00fcmer der HKS health solutions GmbH beim Verkauf an NORD Holding.'>Deal News: CRESCAT Advisory ber\u00e4t die Eigent\u00fcmer der HKS health solutions GmbH beim Verkauf an NORD Holding.\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >M\u00e4rz 2025<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/argisht\/\" title=\"Beitr\u00e4ge von Argisht\" rel=\"author\">Argisht<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>NORD Holding setzt ihre Investitionsstrategie im CDMO-Bereich f\u00fcr Nahrungserg\u00e4nzungs- und Arzneimittel fort und \u00fcbernimmt die HKS health solutions (\u201eHKS\u201c) mit zwei Produktionsstandorten in Deutschland (DRONANIA pharmaceuticals GmbH, Bad-W\u00f6rishofen) und \u00d6sterreich (HKS GmbH, Lengau). Beide Unternehmen werden die ersten Mitglieder der neugegr\u00fcndeten 1Q Health Group und bilden damit den Grundstein f\u00fcr eine europaweite Expansion und eine [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/hks\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2025\/03\/Deal_News_Crescat_Advisory_HKS_health_solutions_GmbH_web-1.jpg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>376<\/span>\n\t\t\t\t\t\t<span itemprop='width'>1030<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>Argisht<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>Argisht<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2025-03-05T12:55:18+01:00\" >2025-03-05 12:55:18<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2025-03-05 13:00:06<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>Deal News: CRESCAT Advisory ber\u00e4t die Eigent\u00fcmer der HKS health solutions GmbH beim Verkauf an NORD Holding.<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-864 post-loop-2 post-parity-even bloglist-excerpt  post-864 post type-post status-publish format-standard hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/deal-news-crescat-advisory-beraet-hks-health-solutions-bei-finanzierung-fuer-gesundes-wachstum\/' rel='bookmark' title='Permanenter Link zu: Deal News: CRESCAT ADVISORY ber\u00e4t HKS Health Solutions bei Finanzierung f\u00fcr gesundes Wachstum'>Deal News: CRESCAT ADVISORY ber\u00e4t HKS Health Solutions bei Finanzierung f\u00fcr gesundes Wachstum\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >Oktober 2023<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/argisht\/\" title=\"Beitr\u00e4ge von Argisht\" rel=\"author\">Argisht<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>Die HKS health solutions GmbH Austria ist ein renommierter Hersteller von Nahrungserg\u00e4nzungsmitteln am Standort Lengau in \u00d6sterreich. 2021 kam es zur Fusion von insgesamt sechs Unternehmen aus der Nahrungserg\u00e4nzungs- und Arzneimittelbranche. Seit dieser Zusammenf\u00fchrung der Einzelgesellschaften zur HKS-Gruppe befindet sich HKS Austria in einer starken Wachstumsphase. Um den Liquidit\u00e4tsbedarf f\u00fcr dieses Wachstum zu decken, ber\u00e4t [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/deal-news-crescat-advisory-beraet-hks-health-solutions-bei-finanzierung-fuer-gesundes-wachstum\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>0<\/span>\n\t\t\t\t\t\t<span itemprop='width'>0<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>Argisht<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>Argisht<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2023-10-26T10:49:04+02:00\" >2023-10-26 10:49:04<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2023-10-26 10:57:11<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>Deal News: CRESCAT ADVISORY ber\u00e4t HKS Health Solutions bei Finanzierung f\u00fcr gesundes Wachstum<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-846 post-loop-3 post-parity-odd bloglist-excerpt with-slider post-846 post type-post status-publish format-standard has-post-thumbnail hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/deal-news-crescat-advisory-beraet-skytender-solutions-bei-bridgefinanzierung\/' rel='bookmark' title='Permanenter Link zu: Deal News: CRESCAT Advisory ber\u00e4t SkyTender Solutions bei Bridgefinanzierung'>Deal News: CRESCAT Advisory ber\u00e4t SkyTender Solutions bei Bridgefinanzierung\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >Oktober 2023<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/crescat-advisory\/\" title=\"Beitr\u00e4ge von crescat Advisory\" rel=\"author\">crescat Advisory<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>CRESCAT Advisory hat die SkyTender Solutions AG bei einer Bridgefinanzierung beraten. Im Rahmen eines Private Placement haben sich Investoren \u00fcber eine Wandelschuldverschreibung an dem Unternehmen beteiligt. SkyTender hat ein revolution\u00e4res Getr\u00e4nkecatering System in Form von als Trolley gebauten Getr\u00e4nkeautomaten entwickelt, mit der Airlines das Getr\u00e4nkecatering v\u00f6llig neu aufstellen k\u00f6nnen und neben erheblichen Kosteneinsparungen auch von [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/deal-news-crescat-advisory-beraet-skytender-solutions-bei-bridgefinanzierung\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2023\/10\/Deal_news_Skytender.jpg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>700<\/span>\n\t\t\t\t\t\t<span itemprop='width'>1920<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>crescat Advisory<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>crescat Advisory<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2023-10-05T11:25:24+02:00\" >2023-10-05 11:25:24<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2023-10-05 11:28:21<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>Deal News: CRESCAT Advisory ber\u00e4t SkyTender Solutions bei Bridgefinanzierung<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-841 post-loop-4 post-parity-even bloglist-excerpt  post-841 post type-post status-publish format-standard hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/ma-review-artikel-finanzierung-von-ma-transaktionen-im-mittelstand-intellectual-property-als-strategisches-asse\/' rel='bookmark' title='Permanenter Link zu: M&#038;A Review Artikel: Finanzierung von M&#038;A-Transaktionen im Mittelstand: Intellectual Property als Strategisches Asse'>M&#038;A Review Artikel: Finanzierung von M&#038;A-Transaktionen im Mittelstand: Intellectual Property als Strategisches Asse\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >August 2023<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/crescat-advisory\/\" title=\"Beitr\u00e4ge von crescat Advisory\" rel=\"author\">crescat Advisory<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>Unser Kollege Holger Linn hat gemeinsam mit Christina Koller und Edelbert H\u00e4fele von PATEV im M&amp;A Review einen Artikel zum Thema &#8222;Finanzierung von M&amp;A-Transaktionen im Mittelstand&#8220; verfasst. &nbsp; Nachfolgend finden Sie den Link zum vollst\u00e4ndigen Artikel. M&amp;A Review Artikel: Finanzierung von M&amp;A-Transaktionen im Mittelstand: Intellectual Property als Strategisches Asset<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/ma-review-artikel-finanzierung-von-ma-transaktionen-im-mittelstand-intellectual-property-als-strategisches-asse\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>0<\/span>\n\t\t\t\t\t\t<span itemprop='width'>0<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>crescat Advisory<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>crescat Advisory<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2023-08-02T14:05:59+02:00\" >2023-08-02 14:05:59<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2023-08-02 14:05:59<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>M&#038;A Review Artikel: Finanzierung von M&#038;A-Transaktionen im Mittelstand: Intellectual Property als Strategisches Asse<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-814 post-loop-5 post-parity-odd bloglist-excerpt  post-814 post type-post status-publish format-standard hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/transaction-readiness-ist-wichtiger-denn-je-ein-leitfaden\/' rel='bookmark' title='Permanenter Link zu: Transaction Readiness ist wichtiger denn je \u2013 Ein Leitfaden'>Transaction Readiness ist wichtiger denn je \u2013 Ein Leitfaden\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >November 2022<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/crescat-advisory\/\" title=\"Beitr\u00e4ge von crescat Advisory\" rel=\"author\">crescat Advisory<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>Ein Beitrag \u00fcber Transaction Readiness von Oliver B\u00f6hm, Crescat Advisory GmbH, f\u00fcr die DDIM-Dachgesellschaft Deutsches Interim Management e.V.:\u00a0Die Mehrheit von Eigent\u00fcmern und Managern w\u00fcrden ihr Unternehmen wahrscheinlich als \u201etransaction ready\u201c bezeichnen, also als f\u00e4hig, jederzeit eine Unternehmenstransaktion oder -finanzierung durchf\u00fchren zu k\u00f6nnen. Dies ist in der Realit\u00e4t allerdings selten der Fall. Insbesondere in Zeiten, in [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/transaction-readiness-ist-wichtiger-denn-je-ein-leitfaden\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>0<\/span>\n\t\t\t\t\t\t<span itemprop='width'>0<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>crescat Advisory<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>crescat Advisory<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2022-11-01T10:12:47+01:00\" >2022-11-01 10:12:47<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2022-11-01 10:25:44<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>Transaction Readiness ist wichtiger denn je \u2013 Ein Leitfaden<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-803 post-loop-6 post-parity-even bloglist-excerpt  post-803 post type-post status-publish format-standard hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/steigende-anforderungen-banken\/' rel='bookmark' title='Permanenter Link zu: Steigende Anforderungen der Banken bei Kreditvergaben stellen Unternehmen vor neue Herausforderungen'>Steigende Anforderungen der Banken bei Kreditvergaben stellen Unternehmen vor neue Herausforderungen\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >M\u00e4rz 2022<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/argisht\/\" title=\"Beitr\u00e4ge von Argisht\" rel=\"author\">Argisht<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>Ein Beitrag von Oliver B\u00f6hm und Roland Kupka, CRESCAT Advisory GmbH, f\u00fcr die DDIM &#8211; Dachgesellschaft Deutsches Interim Management e.V.: Die Beurteilung der Kreditw\u00fcrdigkeit eines Unternehmens durch Banken wurde im Rahmen der Kreditvergabe seit jeher stets ausgesprochen retrospektiv gehandhabt. Dies soll sich nun \u00e4ndern und stellt sowohl Kreditnehmer als auch Kreditgeber vor neue Herausforderungen. Die [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/steigende-anforderungen-banken\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>0<\/span>\n\t\t\t\t\t\t<span itemprop='width'>0<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>Argisht<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>Argisht<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2022-03-08T13:16:46+01:00\" >2022-03-08 13:16:46<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2022-03-08 13:18:17<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>Steigende Anforderungen der Banken bei Kreditvergaben stellen Unternehmen vor neue Herausforderungen<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-796 post-loop-7 post-parity-odd bloglist-excerpt with-slider post-796 post type-post status-publish format-standard has-post-thumbnail hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/roman_loidl\/' rel='bookmark' title='Permanenter Link zu: CRESCAT verst\u00e4rkt Wiener Team weiter'>CRESCAT verst\u00e4rkt Wiener Team weiter\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >Februar 2022<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/argisht\/\" title=\"Beitr\u00e4ge von Argisht\" rel=\"author\">Argisht<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>[vc_row][vc_column][vc_column_text]Roman Loidl verf\u00fcgt \u00fcber mehr als 20 Jahre Berufserfahrung im Bankwesen und als Bankenpr\u00fcfer mit Fokus auf regionale \u00f6sterreichische Kreditinstitute. Seine Verantwortung umfasste dabei sowohl Markt- als auch Marktfolget\u00e4tigkeiten und die Pr\u00fcfungsleitung von Sparkassen und Privatstiftungen. In seiner beruflichen Laufbahn sammelte er Erfahrungen in den Bereichen Unternehmens- und Immobilienfinanzierung, Finanzanalyse, Bilanzierung, Risikomanagement, Restrukturierung\/Sanierung und der [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/roman_loidl\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2022\/02\/1645197689023.jpg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>1200<\/span>\n\t\t\t\t\t\t<span itemprop='width'>1200<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>Argisht<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>Argisht<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2022-02-21T07:58:25+01:00\" >2022-02-21 07:58:25<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2022-02-21 08:00:03<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>CRESCAT verst\u00e4rkt Wiener Team weiter<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-791 post-loop-8 post-parity-even bloglist-excerpt with-slider post-791 post type-post status-publish format-standard has-post-thumbnail hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/galvanoform\/' rel='bookmark' title='Permanenter Link zu: CRESCAT ber\u00e4t die Galvanoform bei der Strukturierung von Wachstumskapital'>CRESCAT ber\u00e4t die Galvanoform bei der Strukturierung von Wachstumskapital\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >Februar 2022<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/argisht\/\" title=\"Beitr\u00e4ge von Argisht\" rel=\"author\">Argisht<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>[vc_row][vc_column][vc_column_text]Die CRESCAT Advisory GmbH (CRESCAT) hat die Galvanoform Gesellschaft f\u00fcr Galvanoplastik GmbH (Galvanoform) bei der Strukturierung von Wachstumskapital beraten. Mit Hilfe der eingeworbenen Mittel wird die Gesellschaft ihren Wachstumskurs fortsetzen und ihre marktf\u00fchrende Stellung weiter ausbauen. \u00dcber Galvanoform Die Galvanoform, ein in 1956 gegr\u00fcndetes und unver\u00e4ndert in Privatbesitz befindliches Unternehmen ist ein Hersteller von Pr\u00e4zisions\u00adwerkzeugen [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/galvanoform\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2022\/02\/Crescat\u2013Galvanoform.jpg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>343<\/span>\n\t\t\t\t\t\t<span itemprop='width'>755<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>Argisht<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>Argisht<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2022-02-17T16:23:06+01:00\" >2022-02-17 16:23:06<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2022-02-17 16:27:16<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>CRESCAT ber\u00e4t die Galvanoform bei der Strukturierung von Wachstumskapital<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-769 post-loop-9 post-parity-odd bloglist-excerpt  post-769 post type-post status-publish format-standard hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/beitrag-oliver-boehm-biospektrum\/' rel='bookmark' title='Permanenter Link zu: Beitrag Oliver B\u00f6hm BIOspektrum \u2013 Wachstumsfinanzierungen in der Biotech-Industrie \u2013 Was Kapitalgebern wichtig ist'>Beitrag Oliver B\u00f6hm BIOspektrum \u2013 Wachstumsfinanzierungen in der Biotech-Industrie \u2013 Was Kapitalgebern wichtig ist\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >Februar 2022<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/argisht\/\" title=\"Beitr\u00e4ge von Argisht\" rel=\"author\">Argisht<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>[vc_row][vc_column][vc_column_text]Die Kapitalaufnahme von deutschen Biotechnologieunternehmen hat mit u\u0308ber drei Milliarden Euro im Jahr 2020 einen neuen H\u00f6chststand erreicht und sich im Gegensatz zu 2019 mehr als verdoppelt. Rund 85 Prozent davon war Eigenkapital. Allerdings gingen rund drei Viertel des gesamten Kapitals an lediglich vier bereits etablierte Unternehmen \u2013 BioNTech, CureVac, Morphosys und Evotec \u2013 und [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/beitrag-oliver-boehm-biospektrum\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>0<\/span>\n\t\t\t\t\t\t<span itemprop='width'>0<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>Argisht<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>Argisht<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2022-02-04T13:15:53+01:00\" >2022-02-04 13:15:53<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2022-02-21 08:19:12<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>Beitrag Oliver B\u00f6hm BIOspektrum \u2013 Wachstumsfinanzierungen in der Biotech-Industrie \u2013 Was Kapitalgebern wichtig ist<\/span><\/span><\/span><\/article><article class='post-entry post-entry-type-standard post-entry-762 post-loop-10 post-parity-even post-entry-last bloglist-excerpt with-slider post-762 post type-post status-publish format-standard has-post-thumbnail hentry category-allgemein'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" ><div class='blog-meta'><\/div><div class='entry-content-wrapper clearfix standard-content'><header class=\"entry-content-header\"><h2 class='post-title entry-title '  itemprop=\"headline\" >\t<a href='https:\/\/www.crescat-advisory.de\/aktuelles\/zukunftsforum\/' rel='bookmark' title='Permanenter Link zu: CRESCAT referierte zum Thema \u201eerfolgreiche Unternehmensnachfolge\u201c beim 2. Zukunftsforum Familienunternehmen in Kitzb\u00fchel'>CRESCAT referierte zum Thema \u201eerfolgreiche Unternehmensnachfolge\u201c beim 2. Zukunftsforum Familienunternehmen in Kitzb\u00fchel\t\t\t<span class='post-format-icon minor-meta'><\/span>\t<\/a><\/h2><span class='post-meta-infos'><time class='date-container minor-meta updated' >Dezember 2021<\/time><span class='text-sep text-sep-date'>\/<\/span><span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/category\/allgemein\/\" rel=\"tag\">Allgemein<\/a> <\/span><span class=\"text-sep text-sep-cat\">\/<\/span><span class=\"blog-author minor-meta\">von <span class=\"entry-author-link\"  itemprop=\"author\" ><span class=\"author\"><span class=\"fn\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/author\/argisht\/\" title=\"Beitr\u00e4ge von Argisht\" rel=\"author\">Argisht<\/a><\/span><\/span><\/span><\/span><\/span><\/header><p>[vc_row][vc_column][vc_column_text]CRESCAT begr\u00fc\u00dfte mit der Schellhammer Capital Bank AG, \u00d6sterreichs gr\u00f6\u00dfter Privatbank, 50 geladene Familienunternehmer aus \u00d6sterreich und S\u00fcddeutschland zur Veranstaltung mit Themenschwerpunkt \u201eUnternehmensnachfolge\u201c in Kitzb\u00fchel. Roland Hausenbichl, Gr\u00fcndungspartner von CRESCAT Advisory GmbH, erl\u00e4uterte die grunds\u00e4tzlichen M\u00f6glichkeiten einer externen Unternehmensnachfolge und den Prozess eines Unternehmensverkaufs. Besonderes Augenmerk ist auf eine umfassende Vorbereitung des Verkaufsprozesses zur Optimierung [&hellip;]<\/p>\n<div class=\"read-more-link\"><a href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/zukunftsforum\/\" class=\"more-link\">Weiterlesen<span class=\"more-link-arrow\"><\/span><\/a><\/div><footer class=\"entry-footer\"><\/footer><div class='post_delimiter'><\/div><\/div><div class='post_author_timeline'><\/div><span class='hidden'>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" >\n\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/12\/Zukunftsforum_Crescat-1.jpg<\/span>\n\t\t\t\t\t\t<span itemprop='height'>474<\/span>\n\t\t\t\t\t\t<span itemprop='width'>907<\/span>\n\t\t\t\t<\/span>\n\t\t\t\t<span class='av-structured-data'  itemprop=\"publisher\" itemtype=\"https:\/\/schema.org\/Organization\" itemscope=\"itemscope\" >\n\t\t\t\t\t\t<span itemprop='name'>Argisht<\/span>\n\t\t\t\t\t\t<span itemprop='logo' itemscope itemtype='https:\/\/schema.org\/ImageObject'>\n\t\t\t\t\t\t\t<span itemprop='url'>https:\/\/www.crescat-advisory.de\/aktuelles\/wp-content\/uploads\/2021\/04\/crescat-advisory-logo.svg<\/span>\n\t\t\t\t\t\t <\/span>\n\t\t\t\t<\/span><span class='av-structured-data'  itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><span itemprop='name'>Argisht<\/span><\/span><span class='av-structured-data'  itemprop=\"datePublished\" datetime=\"2021-12-31T09:46:51+01:00\" >2021-12-31 09:46:51<\/span><span class='av-structured-data'  itemprop=\"dateModified\" itemtype=\"https:\/\/schema.org\/dateModified\" >2021-12-31 09:53:38<\/span><span class='av-structured-data'  itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/mainEntityOfPage\" ><span itemprop='name'>CRESCAT referierte zum Thema \u201eerfolgreiche Unternehmensnachfolge\u201c beim 2. Zukunftsforum Familienunternehmen in Kitzb\u00fchel<\/span><\/span><\/span><\/article><div class='bloglist-excerpt'><nav class='pagination'><span class='pagination-meta'>Seite 1 von 4<\/span><span class='current'>1<\/span><a href='https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/pages\/17\/page\/2\/' class='inactive next_page' >2<\/a><a href='https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/pages\/17\/page\/3\/' class='inactive' >3<\/a><a href='https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/pages\/17\/page\/4\/' class='inactive' >4<\/a><\/nav>\n<\/div><\/div>\n\n","protected":false},"excerpt":{"rendered":"[vc_row][vc_column][vc_column_text]CRESCAT begr\u00fc\u00dfte mit der Schellhammer Capital Bank AG, \u00d6sterreichs gr\u00f6\u00dfter Privatbank, 50 geladene Familienunternehmer aus \u00d6sterreich und S\u00fcddeutschland zur Veranstaltung mit Themenschwerpunkt \u201eUnternehmensnachfolge\u201c in Kitzb\u00fchel. Roland Hausenbichl, Gr\u00fcndungspartner von CRESCAT Advisory GmbH, erl\u00e4uterte die grunds\u00e4tzlichen M\u00f6glichkeiten einer externen Unternehmensnachfolge und den Prozess eines Unternehmensverkaufs. Besonderes Augenmerk ist auf eine umfassende Vorbereitung des Verkaufsprozesses zur Optimierung [...]","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-17","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CRESCAT Advisory \u2013 Aktuelles<\/title>\n<meta name=\"description\" content=\"Hier erfahren Sie alle Neuigkeiten \u00fcber CRESCAT Advisory \u2013 Interviews, Beitr\u00e4ge und Deal News.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.crescat-advisory.de\/aktuelles\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRESCAT Advisory \u2013 Aktuelles\" \/>\n<meta property=\"og:description\" content=\"Hier erfahren Sie alle Neuigkeiten \u00fcber CRESCAT Advisory \u2013 Interviews, Beitr\u00e4ge und Deal News.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.crescat-advisory.de\/aktuelles\/\" \/>\n<meta property=\"og:site_name\" content=\"Aktuelles\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-23T15:15:40+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/\",\"url\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/\",\"name\":\"CRESCAT Advisory \u2013 Aktuelles\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/#website\"},\"datePublished\":\"2021-04-09T09:20:26+00:00\",\"dateModified\":\"2021-06-23T15:15:40+00:00\",\"description\":\"Hier erfahren Sie alle Neuigkeiten \u00fcber CRESCAT Advisory \u2013 Interviews, Beitr\u00e4ge und Deal News.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CRESCAT Advisory \u2013 Aktuelles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/#website\",\"url\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/\",\"name\":\"Aktuelles\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.crescat-advisory.de\\\/aktuelles\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRESCAT Advisory \u2013 Aktuelles","description":"Hier erfahren Sie alle Neuigkeiten \u00fcber CRESCAT Advisory \u2013 Interviews, Beitr\u00e4ge und Deal News.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.crescat-advisory.de\/aktuelles\/","og_locale":"de_DE","og_type":"article","og_title":"CRESCAT Advisory \u2013 Aktuelles","og_description":"Hier erfahren Sie alle Neuigkeiten \u00fcber CRESCAT Advisory \u2013 Interviews, Beitr\u00e4ge und Deal News.","og_url":"https:\/\/www.crescat-advisory.de\/aktuelles\/","og_site_name":"Aktuelles","article_modified_time":"2021-06-23T15:15:40+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.crescat-advisory.de\/aktuelles\/","url":"https:\/\/www.crescat-advisory.de\/aktuelles\/","name":"CRESCAT Advisory \u2013 Aktuelles","isPartOf":{"@id":"https:\/\/www.crescat-advisory.de\/aktuelles\/#website"},"datePublished":"2021-04-09T09:20:26+00:00","dateModified":"2021-06-23T15:15:40+00:00","description":"Hier erfahren Sie alle Neuigkeiten \u00fcber CRESCAT Advisory \u2013 Interviews, Beitr\u00e4ge und Deal News.","breadcrumb":{"@id":"https:\/\/www.crescat-advisory.de\/aktuelles\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.crescat-advisory.de\/aktuelles\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.crescat-advisory.de\/aktuelles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.crescat-advisory.de\/aktuelles\/"},{"@type":"ListItem","position":2,"name":"CRESCAT Advisory \u2013 Aktuelles"}]},{"@type":"WebSite","@id":"https:\/\/www.crescat-advisory.de\/aktuelles\/#website","url":"https:\/\/www.crescat-advisory.de\/aktuelles\/","name":"Aktuelles","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.crescat-advisory.de\/aktuelles\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/pages\/17","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/comments?post=17"}],"version-history":[{"count":68,"href":"https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/pages\/17\/revisions"}],"predecessor-version":[{"id":875,"href":"https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/pages\/17\/revisions\/875"}],"wp:attachment":[{"href":"https:\/\/www.crescat-advisory.de\/aktuelles\/wp-json\/wp\/v2\/media?parent=17"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}